Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced‐intensity conditioning regimens
Mats Merup(Karolinska University Hospital), Gunnar Birgegård(Uppsala University Hospital), Hareth Nahi(Karolinska University Hospital), Björn Andréasson(NU Hospital Group), Mats Brune(Sahlgrenska University Hospital), Vladimir Lazarević(Skåne University Hospital), Claes Malm(Karolinska University Hospital), Lars Nilsson(Skåne University Hospital), Jack Kutti(Sahlgrenska University Hospital), Katarina LeBlanc(Karolinska University Hospital)
Cited by 56
Related Papers
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
|Journal of Clinical Oncology|2012|461
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009
|Bone Marrow Transplantation|2009|385